Clinical samples from lung cancer patients have demonstrated the co-expression of CXCR4, p-STAT3, and VEGF-A, suggesting a potential role in tumor progression and angiogenesis in non-small cell lung cancer (NSCLC) [122]. Here, STAT3 is linked to neoplasm.